Advertisement

Hepatic Encephalopathy and Benzodiazepine Receptor Ligands

  • E. Anthony Jones
  • Sergio H. Gammal
  • Anthony S. Basile
  • Kevin D. Mullen
  • Mark L. Bassett
  • Daniel F. Schafer
  • Phil Skolnick
Chapter
Part of the Experimental Biology and Medicine book series (EBAM, volume 22)

Abstract

Benzodiazepine (BZ) receptor ligands interact with specific binding sites on the GABAA receptor/chloride channel complex on neurons in the central nervous system (CNS) (1) (Figure 1). Such ligands could contribute to or ameliorate hepatic encephalopathy (HE) if the supra-molecular complex itself is involved in this syndrome. The complex includes distinct receptors for BZ ligands and GABA, and a chloride ionophore on which there are binding sites for barbiturates and cage convulsants, such as Picrotoxin. Activation of the effector component of this complex, the chloride channel, is mediated by the binding of GABA to its receptor and is potentiated by the binding of a BZ agonist or a barbiturate to discrete loci on the complex. Activation induces conformational changes in the complex which result in opening of the chloride channel and hyperpolarization of the neuron (1) (Figure 1). This GABA-gated chloride ion conductance is the basis of GABA-mediated inhibitory neurotransmission or “GABAergic tone.”

Keywords

Hepatic Encephalopathy Fulminant Hepatic Failure Ammonia Metabolism Visual Evoke Response GABAergic Tone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paul S.M., Marangos P.J., and Skolnick P. (1981) The benzodiazepine-GABA-chloride ionophore receptor complex. Common site of minor tranquillizer action. Biol. Psych. 16, 213–229.Google Scholar
  2. 2.
    Bassett M.L., Mullen K.D., Skolnick P. et al. (1987) Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA/benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 93, 1069–1077.PubMedGoogle Scholar
  3. 3.
    Schafer D.F. Pappas S.C., Brody L.E. et al. (1984) Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Gastroenterology 86, 540–545.PubMedGoogle Scholar
  4. 4.
    Jones D.B., Mullen K.D., Roessle M. et al. (1987) Hepatic encephalopathy: application of visual evoked responses to test hypotheses of its pathogenesis in rats. J. Hepatol. 4, 118–126.PubMedCrossRefGoogle Scholar
  5. 5.
    Gammal S.H., Jones E.A., Bassett M.L. et al. (1988) Antagonists of the GABA/benzodiazepine receptor complex ameliorate hepatic encephalopathy in two models of fulminant hepatic failure, in Advances in Ammonia Metabolism and Hepatic Encephalopathy. (Soeters P.B., Wilson J.H.P., Meijer A.J., and Holm E. eds), pp. 325–332. Excerpta Medica, Amsterdam.Google Scholar
  6. 6.
    Study R.E., and Barker J.L. (1981) Diazepam and (-)-pentobarbital Fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured neurons. Proc. Natl. Acad. Sci. USA 78, 7180–7184.PubMedCrossRefGoogle Scholar
  7. 7.
    Schafer D.F., Fowler J.M., Brody L.E. et al. (1980) Hepatic coma and inhibitory neurotransmission: the enteric bacterial flora as a source of γ-aminobuty-ric acid. Gastroenterology 79, 1052. (Abstract).Google Scholar
  8. 8.
    Schafer D.F. Jones E.A. (1982) Hepatic encephalopathy and the γ-aminobutyric acid neuro-transmitter system. Lancet i, 18–20.Google Scholar
  9. 9.
    Blitzer B.L., Waggoner J.G., Jones E.A. et al. (1978) A model of fulminant hepatic failure in the rabbit. Gastroenterology 74, 664–671.PubMedGoogle Scholar
  10. 10.
    Jones E.A., and Skolnick P. (1989) Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy, in Progress in Liver Diseases, volume IX. (Popper H., Schaffner F., eds). W.B. Saunders, Philadelphia, ‘In press’.Google Scholar
  11. 11.
    Ferreira M.R., Gammal S.H., and Jones E.A. (1983) Hepatic encephalopathy (HE); Evidence of increased GABA-mediated neurotransmission in a rat model of fulminant hepatic failure (FHF). Gastroenterology 94, A616. (Abstract).Google Scholar
  12. 12.
    Olsen R.W. (1982) Drug interactions at the GABA receptor-ionophore complex. Ann. Rev. Pharmacol. Toxicol. 22, 245–277.CrossRefGoogle Scholar
  13. 13.
    Karlsson A., Fonnum F., Malthe-Sorrenssen D. et al. (1974) Effect of the convulsive agent 3, mercapto-propionic acid on the levels of GABA, other anino acids and glutamate decarboxylase in different regions of the rat brain. Biochem. Pharmacol. 23, 3053–3061.Google Scholar
  14. 14.
    Basile A.S., Gammal S.H., Milien K.D. et al. (1988) Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J. Neurosc. 8, 2414–2421.Google Scholar
  15. 15.
    Baraldi M., and Zeneroli M.L. (1982) Experimental hepatic encephalopathy: changes in the binding of γ-aminobutyric acid. Science 216, 427–429.PubMedCrossRefGoogle Scholar
  16. 16.
    Schafer D.F., Fowler J.M., Munson P.J. et al. (1983) Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102, 870–880.PubMedGoogle Scholar
  17. 17.
    Maddison J.E., Dodd P.R., Morrison M. et al. (1987) Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology 7, 621–628.PubMedCrossRefGoogle Scholar
  18. 18.
    Roy S., Pomier-Layrargues G., Butterworth R.F. et al. (1988) Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 8, 845–849.PubMedCrossRefGoogle Scholar
  19. 19.
    Ferenci P., Zimmerman C., and Ebner J. (1988) Post-synaptic γ-aminobutyric acid (GABA) receptors in thioacetamide-induced acute liver failure in rats, in Advances in Ammonia Metabolism and Hepatic Encephalopathy. (Soeters P.B., Wilson J.H.P. Meijer A.J. and Holm E. eds), pp. 218–224. Excerpta Medica, Amsterdam.Google Scholar
  20. 20.
    Bassett M.L. Mullen K.D. Scholz B., et al. (1985) Increased brain GABA uptake in precoma encephalopathy in a rabbit model of fulminant hepatic failure. Hepatology 5, 1032. (Abstract).Google Scholar
  21. 21.
    Squires R.F. (1984) Benzodiazepine receptors, in Handbook of Neurochemistry, 2nd ed. Volume 6. (Lajtha A. ed), pp. 261–306. Plenum, New York.Google Scholar
  22. 22.
    Mullen K.D., Martin J.V., Mendelson W.B. et al. (1988) Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet i, 457–459.Google Scholar
  23. 23.
    Chiappa K.H., and Ropper A.H. (1982) Evoked potentials in clinical medicine. N. Eng. J. Med. 306, 1140–1147.CrossRefGoogle Scholar
  24. 24.
    Zemon V. Kaplan E., and Katloff F. (1980) Bicuculline enhances a negative component and diminishes a positive component of the visual evoked cortical potential in the cat. Proc. Natl. Acad. Sci. USA 77, 7476–7478.PubMedCrossRefGoogle Scholar
  25. 25.
    Nakayama K., (1982) The relationship of visual evoked potentials to cortical physiology. Ann. N. Y. Acad. Sci. 388, 21–36.PubMedCrossRefGoogle Scholar
  26. 26.
    Dyer R.S., Jensen K.F. and Boyer W.K. (1987) Focal lesion of visual cortex: effects on visual evoked potentials in rats. Exp. Neurol. 95, 100–115.PubMedCrossRefGoogle Scholar
  27. 27.
    Traber P.G. Ganger D.R., and Blei A.T. (1986) Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects of intracranial pressure. Gastroenterology 91, 1347–1356.PubMedGoogle Scholar
  28. 28.
    Traber P.G., Canto M.D., Ganger D.R. et al. (1987) Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure. Ultrastructure and integrity of the blood brain barrier. Hepatology 7, 1272–1277.PubMedCrossRefGoogle Scholar
  29. 29.
    Mullen K.D., Schafer D.F., Cuchi P. et al. (1988) Evaluation of the suitability of galactosamineinduced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and the rabbit, in Advances in Ammonia Metabolism and Hepatic Encephalopathy. (Soeters P.B. Wilson J.H.P., Meijer A.J., and Holm E. eds), pp. 205–212. Excerpta Medica, Amsterdam.Google Scholar
  30. 30.
    Hunkeler W., Mohler H., Pieri L. et al. (1981) Selective antagonists of benzodiazepines. Nature 290, 514–516.PubMedCrossRefGoogle Scholar
  31. 31.
    Bonetti E., Pieri L., Cumin R. et al. (1982) Benzo-diazepine antagonist Ro 15–1788: Neurological and behavioral effects. Psychopharmacology 78, 8–18.PubMedCrossRefGoogle Scholar
  32. 32.
    Haefely W. (1983) Antagonists of benzodiazepines: functional aspects, in Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology. (Biggio G., and Costa E. eds), pp. 73–93. Raven Press, New York.Google Scholar
  33. 33.
    Geller D. Gammal S.H., Mullen K.D. et al. (1988) An improved rat model of hepatic encephalopathy due to fulminant hepatic failure. The importance of supportive therapy, in Advances in Ammonia Metabolism and Hepatic Encephalopathy. (Soeters P.B., Wilson J.H.P., Meijer A.J., and Holm E. eds), pp. 213–217. Excerpta Medica, Amsterdam.Google Scholar
  34. 34.
    Gammal S.H., Basile A.S., Geller D. et al. Involvement of the benzodiazepine receptor in hepatic encephalopathy: Quantitative behavioral and electrophysiological evidence in a rat model. (In preparation).Google Scholar
  35. 35.
    Baraldi M., Zeneroli M.L., Ventura E. et al. (1984) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin. Sci. 67, 167–175.Google Scholar
  36. 36.
    Mullen K.D. Szanter K.M., Kaminsky K. et al. (1989) Detection and characterization of endogenous benzodiazepine activity in both animal models and humans with hepatic encephalopathy. (This volume).Google Scholar
  37. 37.
    Basile A.S., Ostrowski N.L., Gammal S.H. et al. (1989) The GABAA receptor complex in hepatic encephalopathy: Autoradiographic evidence for the presence of an endogenous benzodiazepine receptor ligand. Gastroenterology. (Abstract).Google Scholar
  38. 38.
    Basile A.S. Gammal S.H., Jones E.A. et al. (1989) The GABAA receptor complex in an experimental model of hepatic encephalopathy: Evidence for elevated levels of an endogenous benzodiazepine receptor ligand. Gastroenterology. (Abstract).Google Scholar

Copyright information

© The Humana Press Inc. 1989

Authors and Affiliations

  • E. Anthony Jones
    • 1
  • Sergio H. Gammal
    • 1
  • Anthony S. Basile
    • 1
  • Kevin D. Mullen
    • 1
  • Mark L. Bassett
    • 1
  • Daniel F. Schafer
    • 1
  • Phil Skolnick
    • 1
  1. 1.Liver Diseases Section and Laboratory of Neuroscience, NIDDKNational Institutes of HealthBethesdaUSA

Personalised recommendations